Home
>
National Drug Code (NDC)
>
RINKEL MOLD MIX C
RINKEL MOLD MIX C - 54575-230-10 - (absidia capillata and acrothecium robustum and microsporum audouinii and microsporum canis and apiospora montagnei and phycomyces blakesleeanus and sporotrichum pruinosum and stachybotrys chartarum an)
Drug Information of RINKEL MOLD MIX C
| Product NDC: | 54575-230 |
| Proprietary Name: | RINKEL MOLD MIX C |
| Non Proprietary Name: | absidia capillata and acrothecium robustum and microsporum audouinii and microsporum canis and apiospora montagnei and phycomyces blakesleeanus and sporotrichum pruinosum and stachybotrys chartarum an |
| Active Ingredient(s): | .076; .077; .077; .077; .077; .077; .077; .077; .077; .077; .077; .077; .077 g/20mL; g/20mL; g/20mL; g/20mL; g/20mL; g/20mL; g/20mL; g/20mL; g/20mL; g/20mL; g/20mL; g/20mL; g/20mL & nbsp; absidia capillata and acrothecium robustum and microsporum audouinii and microsporum canis and apiospora montagnei and phycomyces blakesleeanus and sporotrichum pruinosum and stachybotrys chartarum an |
| Administration Route(s): | PERCUTANEOUS; SUBCUTANEOUS |
| Dosage Form(s): | INJECTION, SOLUTION |
| Coding System: | National Drug Codes(NDC) |
Labeler Information of RINKEL MOLD MIX C
| Product NDC: | 54575-230 |
| Labeler Name: | Allergy Laboratories, Inc. |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | BLA101376 |
| Marketing Category: | BLA |
| Start Marketing Date: | 19671207 |
Package Information of RINKEL MOLD MIX C
| Package NDC: | 54575-230-10 |
| Package Description: | 10 mL in 1 VIAL, MULTI-DOSE (54575-230-10) |
NDC Information of RINKEL MOLD MIX C
| NDC Code | 54575-230-10 |
| Proprietary Name | RINKEL MOLD MIX C |
| Package Description | 10 mL in 1 VIAL, MULTI-DOSE (54575-230-10) |
| Product NDC | 54575-230 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | absidia capillata and acrothecium robustum and microsporum audouinii and microsporum canis and apiospora montagnei and phycomyces blakesleeanus and sporotrichum pruinosum and stachybotrys chartarum an |
| Dosage Form Name | INJECTION, SOLUTION |
| Route Name | PERCUTANEOUS; SUBCUTANEOUS |
| Start Marketing Date | 19671207 |
| Marketing Category Name | BLA |
| Labeler Name | Allergy Laboratories, Inc. |
| Substance Name | ABSIDIA CAPILLATA; ACROTHECIUM ROBUSTUM; APIOSPORA MONTAGNEI; MICROSPORUM AUDOUINII; MICROSPORUM CANIS; PHYCOMYCES BLAKESLEEANUS; SPOROTRICHUM PRUINOSUM; STACHYBOTRYS CHARTARUM; SYNCEPHALASTRUM RACEMOSUM; TETRACOCCOSPORIUM PAXIANUM; THERMOMYCES LANUGINOSUS; TRICHOSPORON CUTANEUM; VERTICILLIUM ALBO-ATRUM |
| Strength Number | .076; .077; .077; .077; .077; .077; .077; .077; .077; .077; .077; .077; .077 |
| Strength Unit | g/20mL; g/20mL; g/20mL; g/20mL; g/20mL; g/20mL; g/20mL; g/20mL; g/20mL; g/20mL; g/20mL; g/20mL; g/20mL |
| Pharmaceutical Classes | Non-Standardized Fungal Allergenic Extract [EPC],Increased Histamine Release [PE],Cell-mediated Immunity [PE],Increased IgG Production [PE],Fungal Proteins [Chemical/Ingredient],Allergens [Chemical/Ingredient],Non-Standardized Fungal Allergenic Extract [EPC],Increased Histamine Release [PE],Cell-mediated Immunity [PE],Increased IgG Production [PE],Fungal Proteins [Chemical/Ingredient],Allergens [Chemical/Ingredient],Non-Standardized Fungal Allergenic Extract [EPC],Increased Histamine Release [PE],Cell-mediated Immunity [PE],Increased IgG Production [PE],Fungal Proteins [Chemical/Ingredient],Allergens [Chemical/Ingredient],Non-Standardized Fungal Allergenic Extract [EPC],Increased Histamine Release [PE],Cell-mediated Immunity [PE],Fungal Proteins [Chemical/Ingredient],Allergens [Chemical/Ingredient],Non-Standardized Fungal Allergenic Extract [EPC],Increased Histamine Release [PE],Cell-mediated Immunity [PE],Increased IgG Production [PE],Fungal Proteins [Chemical/Ingredient],Allergens [Chemical/Ingredient],Non-Standardized Fungal Allergenic Extract [EPC],Increased Histamine Release [PE],Cell-mediated Immunity [PE],Increased IgG Production [PE],Fungal Proteins [Chemical/Ingredient],Allergens [Chemical/Ingredient],Non-Standardized Fungal Allergenic Extract [EPC],Increased Histamine Release [PE],Cell-mediated Immunity [PE],Increased IgG Production [PE],Fungal Proteins [Chemical/Ingredient],Allergens [Chemical/Ingredient],Non-Standardized Fungal Allergenic Extract [EPC],Increased Histamine Release [PE],Cell-mediated Immunity [PE],Increased IgG Production [PE],Fungal Proteins [Chemical/Ingredient],Allergens [Chemical/Ingredient],Non-Standardized Fungal Allergenic Extract [EPC],Increased Histamine Release [PE],Cell-mediated Immunity [PE],Increased IgG Production [PE],Fungal Proteins [Chemical/Ingredient],Allergens [Chemical/Ingredient],Non-Standardized Fungal Allergenic Extract [EPC],Increased Histamine Release [PE],Cell-mediated Immunity [PE],Increased IgG Production [PE],Fungal Proteins [Chemical/Ingredient],Allergens [Chemical/Ingredient] |
